Reduced sensitivity of mouse Brca1-wild type tumors to platinum treatment cannot be attributed to slower tumor growth, since growth kinetics are similar between Brca1-deficient and -wild type tumors subsequent to establishment and prior to treatment (Fig. S3). The gene discussed is BRCA1; the disease is neoplasm.